Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHOP vs c-ATT Regimen in High Risk T Cell Lymphoma
NCT01788137Phase 3Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jan 2008
- Primary completion
- Apr 2017
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands, Covalent Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cyclophosphamide, doxorubicin, vincristine, prednisone, bleomycin in T-cell lymphoma, sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
cyclophosphamidedoxorubicinvincristineprednisonebleomycin
03
Conditions
T-cell lymphoma
Beyond the preview
Go deeper on NCT01788137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01788137.